Proteomic Markers of Dietary Patterns and Chronic Kidney Disease
Apr 16, 2026 - 00:04:50
Radio and PodcastLive Radio & PodcastsScience & Medicine
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management
CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and...
About This Episode
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management is an episode from Clinical Journal of the American Society of...
Podcast
This episode belongs to Clinical Journal of the American Society of Nephrology (CJASN).
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Sep 23, 2024, 00:17:49 long, audio available.
Related Episodes
Continue listening to more episodes from Clinical Journal of the American Society of Nephrology (CJASN).
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1
Mar 18, 2026 - 00:03:54
Finerenone and eGFR Slope
Feb 26, 2026 - 00:03:00
Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure
Feb 18, 2026 - 00:04:06
Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients
Dec 18, 2025 - 00:06:20
Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD
Oct 28, 2025 - 00:03:53
SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease
Sep 30, 2025 - 00:03:47
Questions About This Episode
What is Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management about?
CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.
Where can I listen to Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management?
You can listen to Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management from?
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management is an episode from Clinical Journal of the American Society of Nephrology (CJASN) by Hal Nesbitt.
How long is this episode?
This episode is 00:17:49 long.
When was this episode published?
This episode was published on Sep 23, 2024.
Can I save Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Clinical Journal of the American Society of Nephrology (CJASN)?
Yes. This page shows related episodes from Clinical Journal of the American Society of Nephrology (CJASN) when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management?
You can listen to Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management is from Clinical Journal of the American Society of Nephrology (CJASN) by Hal Nesbitt.
What are the episode details?
Published Sep 23, 2024 and 00:17:49 long